For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240710:nRSJ9267Va&default-theme=true
RNS Number : 9267V Iconic Labs PLC 10 July 2024
Iconic Labs PLC
("Iconic" or the "Company")
Board Changes
Iconic Labs PLC (LSE: ICON) announces that after more than three years of
serving as the CEO and a Director of the Company, Brad Taylor is stepping down
from all positions with immediate effect.
The Company would like to thank Mr Taylor for his expertise, dedication and
professionalism in successfully leading the Company through a complex period
of restructuring that included exiting the Company from administration through
a Company Voluntary Arrangement (CVA), lifting the suspension of trading on
the London Stock Exchange, and entering into negotiations and Heads of Terms
with reverse takeover (RTO) target, ITS Holdings 2023 Ltd.
The Company also announces the appointment of John Farquharson (aged 47) as
Interim CEO and Director with immediate effect. Mr Farquharson has held
senior finance roles within the Tavistock Group of companies since 2010 and
currently serves as Head of Finance at Ultimate Finance Group Ltd. He
graduated from the University of Aberdeen in 1999 with an MA in Accountancy
and German following which he worked at PwC from 1999-2004 where he qualified
as a chartered accountant in 2002. He is a member of the Institute of
Chartered Accountants of Scotland (ICAS) and the Chartered Governance
Institute UK and Ireland.
- Ends -
For more information, please contact:
Iconic Labs via Yellow Jersey PR
John Farquharson
Novum Securities Limited Tel: +44 (0) 20 7399 9400
David Coffman / Daniel Harris
Yellow Jersey PR Tel: +44 (0) 20 3004 9512
Charles Goodwin iconic@yellowjerseypr.com
Annabelle Wills
Bessie Elliot
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAEASXEFAFLEFA